Design Therapeautics Share Price Today
(NASDAQ: DSGN)

Name: Design Therapeautics Share Price Today (NASDAQ: DSGN) - Design Therapeautics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Design Therapeautics share price is $4.93 & ₹428.76 as on 6 Mar 2025, 2.30 'hrs' IST

$4.93

▲

-0.11

(-2.08%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Design Therapeautics share price in Dollar and Rupees. Guide to invest in Design Therapeautics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Design Therapeautics, along with analyst recommendations, forecasts, and comprehensive financials.

Design Therapeautics share price movements

Today's Low: $4.73
Today's High: $5.10
$4.93
4.06%
Downside
Day's Volatility :7.25%
Upside
3.33%
52 Weeks Low: $2.45
52 Weeks High: $7.77
$4.93
50.3%
Downside
52 Weeks Volatility :68.47%
Upside
36.55%

Design Therapeautics (DSGN) Returns

Period	Design Therapeautics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.45%	2.1%	0.0%
6 Months	7.01%	-4.1%	0.0%
1 Year	70.85%	2.2%	0.0%
3 Years	-67.34%	11.8%	-11.6%

Design Therapeautics (DSGN) Key Statistics

in dollars & INR

Previous Close	$5.04
Open	$4.98
Today's High	$5.1
Today's Low	$4.73
Market Capitalization	$255.9M
Today's Volume	$429.2K
52 Week High	$7.77
52 Week Low	$2.4501
Revenue TTM	$33.0K
EBITDA	$-60.2M
Earnings Per Share (EPS)	$-0.85
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.78%

How to invest in Design Therapeautics Stock (DSGN) from India?

It is very easy for Indian residents to invest directly in Design Therapeautics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Design Therapeautics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Design Therapeautics or DSGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Design Therapeautics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Design Therapeautics shares which would translate to 0.176 fractional shares of Design Therapeautics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Design Therapeautics, in just a few clicks!

Returns in Design Therapeautics (DSGN) for Indian investors in Rupees

The Design Therapeautics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Design Therapeautics investment value today

Current value as on today

₹1,72,081

Returns

₹72,081

(+72.08%)

Returns from Design Therapeautics Stock

₹67,119 (+67.12%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Design Therapeautics (DSGN)

33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Design Therapeautics Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Design Therapeautics

SR ONE CAPITAL MANAGEMENT, LP
11.53%
Logos Global Management LP
7.45%
BlackRock Inc
4.56%
Point72 Asset Management, L.P.
3.28%
Baker Bros Advisors LP
3.08%
TANG CAPITAL MANAGEMENT LLC
2.62%

Analyst Recommendation on Design Therapeautics

Hold

0%Buy

62%Hold

37%Sell

Based on 8 Wall street analysts offering stock ratings for Design Therapeautics(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Design Therapeautics Stock (DSGN)

What analysts predicted

Upside of 41.99%

Target:

$7.00

Current:

$4.93

Insights on Design Therapeautics Stock (Ticker Symbol: DSGN)

Price Movement
In the last 7 days, DSGN stock has moved up by 6.3%
DSGN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 114.8%

Design Therapeautics Technicals Summary

Sell

Neutral

Buy

Design Therapeautics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Design Therapeautics (DSGN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Design Therapeautics, Inc.	6.78%	7.01%	70.85%	-67.34%	-87.85%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Design Therapeautics, Inc.	NA	NA	NA	-0.9	-0.18	-0.14	NA	4.46
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Design Therapeautics, Inc.	Hold	$255.9M	-87.85%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Design Therapeautics

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Organization	Design Therapeautics
Employees	54
CEO	Mr. Pratik Shah Ph.D.
Industry	Healthcare

Management People of Design Therapeautics

Name	Title
Mr. Pratik Shah Ph.D.	Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
Dr. Sean Jeffries Ph.D.	Chief Operating Officer
Dr. Aseem Z. Ansari Ph.D.	Co-Founder & Scientific Advisor
Ms. Julie D. Burgess CPA	Chief Accounting Officer
Mr. Mustapha Parekh	General Counsel
Ms. Dawn Giangiulio	Controller

Important FAQs about investing in DSGN Stock from India :

What is Design Therapeautics share price today?

Design Therapeautics share price today stands at $4.93, Open: $4.98 ; Previous Close: $5.04 ; High: $5.10 ; Low: $4.73 ; 52 Week High: $7.77 ; 52 Week Low: $2.45.

The stock opens at $4.98, after a previous close of $5.04. The stock reached a daily high of $5.10 and a low of $4.73, with a 52-week high of $7.77 and a 52-week low of $2.45.

Can Indians buy Design Therapeautics shares?

Yes, Indians can invest in the Design Therapeautics (DSGN) from India.

With INDmoney, you can buy Design Therapeautics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Design Therapeautics at zero transaction cost.

How can I buy Design Therapeautics shares from India?

It is very easy to buy Design Therapeautics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Design Therapeautics (DSGN) be purchased?

Yes, you can buy fractional shares of Design Therapeautics with INDmoney app.

What are the documents required to start investing in Design Therapeautics stocks?

To start investing in Design Therapeautics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.